Equine Joint Injections: When They Help, What to Expect, and How Long They Last

Why Joints Need Local Treatment

Systemic NSAIDs (phenylbutazone, flunixin) reduce whole-body inflammation but reach affected joints at lower concentrations than direct injection. Intra-articular therapy delivers medication directly to the affected joint space, achieving local concentrations not possible systemically. For a horse with mild to moderate osteoarthritis, a joint injection can reduce lameness from 3/5 to 0-1/5 for months -- a dramatic improvement that allows continued athletic function. The goal is not to mask pain and continue damaging work; it is to reduce pathological inflammation and enable the joint to function more normally.

Common Joints and Indications

High-motion joints (fetlock, coffin joint, pastern, hock, knee/carpus, stifle, hip): osteoarthritis is the primary indication. The coffin joint within the hoof is the most commonly injected joint in horses, as navicular syndrome and distal limb OA are prevalent performance horse conditions. The hock (tarsocrural and distal tarsal joints): bone spavin (distal tarsal OA) is an extremely common cause of hind limb lameness that responds well to corticosteroid injection. The stifle (femoropatellar and femorotibial joints): upward fixation of the patella and stifle OA. Diagnosis before injection: nerve blocks to localize lameness to the specific joint, then imaging (radiographs, ultrasound, MRI for complex cases) to characterize the pathology before injecting.

Corticosteroid Options and Duration

Triamcinolone acetonide: most commonly used; potent anti-inflammatory effect; typical duration 2-4 months; may have mild bone-protective effects at appropriate doses. Methylprednisolone acetate: longer-acting but potentially more damaging to cartilage with repeated high-dose use in weight-bearing joints -- most practitioners use methylprednisolone more sparingly than triamcinolone. Betamethasone: used in some protocols, particularly for tendon sheath injections. Corticosteroids do not cause cartilage damage at typical clinical doses when used appropriately; the old concern about 'steroid arthropathy' is largely attributed to overdose or overly frequent injection in already damaged joints. Typical triamcinolone dose: 6-12 mg per joint.

Biologic Therapies

IRAP (Interleukin-1 Receptor Antagonist Protein): the horse's own blood is processed to concentrate endogenous anti-inflammatory proteins; injected into the affected joint. Evidence supports efficacy for moderate OA; multiple injections over several weeks. PRP (Platelet-Rich Plasma): concentrated platelets and growth factors from the horse's blood; promotes tissue healing. ProStride (APS -- Autologous Protein Solution): combines IRAP and PRP elements; single-injection protocol; FDA-approved; some studies show 12-24 month duration. These biologics avoid the rare cartilage concerns associated with corticosteroids and are increasingly used as first-line or adjunctive therapy.

Injection Risks and Aftercare

Septic arthritis is the primary risk: bacterial contamination during injection can cause life-threatening joint infection. Signs appearing 24-72 hours after injection -- sudden severe lameness, hot swollen joint, fever -- require emergency veterinary evaluation. Strict aseptic technique (clipping, surgical scrub, sterile equipment) dramatically reduces this risk. Post-injection rest: typically 24-48 hours of stall rest, then gradual return to work. Annual joint injections in routinely competing horses are common; frequency varies by joint condition and discipline.